Here are the S-3 shelf registrations from Avita Medical, Inc. (RCEL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow RCEL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RCEL filings page.
AVITA Medical, Inc. filed a shelf registration statement to offer up to $200,000,000 of common stock, preferred stock, warrants and units under a Form S-3 shelf prospectus dated March 31, 2026. The prospectus states that specific terms for each offering will be set forth in a prospectus supplement. The company's common stock trades on Nasdaq under the symbol RCEL; the prospectus notes a Nasdaq closing price of $3.63 per share as of March 30, 2026. The prospectus says proceeds are expected to be used for general corporate purposes, including capital expenditures and working capital, with precise uses to be specified in future prospectus supplements.